container

FDA Announces Recall of Alaris Pump Module: AttorneyOne Monitor and Keep Consumers Informed

On May 21, the FDA announced that the Alaris Pump model 8100, version 9.1.18, by CareFusion 303 Inc, is recalled (Class I) because the pump may have a software failure and may not properly delay an infusion. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend
Alaris Pump model 8100 Recall

Alaris Pump model 8100 Recall

If infusion starts earlier or later than intended this could result in serious injury or death

San Diego, CA (PRWEB) May 27, 2014

AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for the Alaris Pump.

The FDA announced on May 21, the Alaris Pump model 8100, version 9.1.18, by CareFusion 303 Inc, is recalled (Class I) because the pump may have a software failure and may not properly delay an infusion. The Alaris Pump Model 8100 by CareFusion 303, Inc. is a large volume infusion pump.

As the FDA notes, this failure also causes the pump to not properly deliver a multidose infusion as expected in certain cases. If infusion starts earlier or later than intended this could result in serious injury or death.

Taking into consideration the latest developments, AttorneyOne.com monitor daily and update the website providing accurate information on all relevant FDA safety alerts. Sean Burke, director of Media Relations at AttorneyOne.com, adds “we are determined to keep an eye on FDA announcements concerning Alaris Pump and inform the public. For that reason", he continues, "our focus should squarely fall on investigating these safety alerts and getting the word out.”

The US FDA informs, “The firm recommends that the previous Alaris Pump module software version 9.1.17 be installed to address this recall. CareFusion will contact all affected customers to schedule the installation of software version 9.1.17. Do NOT use the Alaris Pump module “Delay Until” option. Do NOT use the “Multidose” feature.” And the Agency recommends “As an interim guidance, customers may update their dataset to disable both Delay Options and/or Multidose across all Profiles to prevent the use of “Delay Until” option and/or “Multidose” feature. These are shared configurations with the Alaris Syringe module and if disabled would prevent use of these features with the Alaris Syringe module as well.”

AttorneyOne.com has further information on Alaris Pump at the website including latest major drug and medical products law news.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/05/prweb11883881.htm